<p> The latest ADA update to its "Living" Standards of Medical Care in Diabetes address the use of dulaglutide (Trulicity) following recent CV outcomes data.</p>

The latest ADA update to its "Living" Standards of Medical Care in Diabetes address the use of dulaglutide (Trulicity) following recent CV outcomes data.

Univadis Practice Changers: Dulaglutide not just for T2D with established CVD

If you're a family medicine physician or other primary care clinician, you know how hard it is to keep up with the latest research. The Univadis Practice Changers podcast provides expert analysis on the most essential new evidence in medicine. In 5 minutes or less, you'll hear experts go beyond the details of the latest study to the real-world clinical applications. Univadis Practice Changers is a quick look at essential evidence changing your daily practice.

Share Univadis Practice Changers: Dulaglutide not just for T2D with established CVD

Sign up to save your podcasts

Univadis Practice Changers: Dulaglutide not just for T2D with established CVD

Univadis Practice Changers: Dulaglutide not just for T2D with established CVD